Literature DB >> 1654198

Coexpression of adult T-cell leukemia-derived factor, a human thioredoxin homologue, and human papillomavirus DNA in neoplastic cervical squamous epithelium.

S Fujii1, Y Nanbu, H Nonogaki, I Konishi, T Mori, H Masutani, J Yodoi.   

Abstract

Adult T-cell leukemia-derived factor (ADF) is an autocrine interleukin-2 receptor-inducing factor produced by human T-lymphotropic virus-1 (HTLV-1)-transformed lymphocytes, which has a high structural homology with an endogenous dithiol reducing coenzyme, thioredoxin. Its localization was investigated immunohistochemically in the cervix, using normal tissue (27 samples) and squamous neoplastic tissue (three condylomas, 42 cervical intraepithelial neoplasia [CIN] samples, 34 invasive squamous cell carcinoma samples). The expression of human papillomavirus (HPV) DNA was also studied in serial sections of the same subjects. Normal squamous cells and glandular cells of the cervix were negative for ADF. However, intracytoplasmic and/or intranuclear ADF-positive cells were usually found in the intermediate and superficial layers of the neoplastic squamous epithelium of condylomas (three of three cases) and CIN (35/42 cases). HPV DNA was detected in all condylomas and in 27 of 42 CIN specimens. HPV DNA-positive cells were usually localized in the intermediate and superficial layers of the neoplastic squamous epithelium. These HPV DNA-positive cells were also positive for ADF. Invasive squamous cell carcinoma was also positive for ADF (24/34 cases) and HPV DNA (11/34 cases). The coexpression of HPV DNA and ADF was observed in all HPV DNA-positive cases. Coexistence of HPV DNA and ADF immunopositivity in neoplastic squamous cells of the cervix suggests that ADF expression closely reflects the intracellular event on HPV DNA replication.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1654198     DOI: 10.1002/1097-0142(19911001)68:7<1583::aid-cncr2820680720>3.0.co;2-n

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  15 in total

1.  Functional modulation of estrogen receptor by redox state with reference to thioredoxin as a mediator.

Authors:  S Hayashi; K Hajiro-Nakanishi; Y Makino; H Eguchi; J Yodoi; H Tanaka
Journal:  Nucleic Acids Res       Date:  1997-10-15       Impact factor: 16.971

2.  Nanotechnology of emerging targeting systems.

Authors:  S S Smith
Journal:  Minerva Biotecnol       Date:  2008-09       Impact factor: 3.028

3.  NMR structure of Carcinoscorpius rotundicauda thioredoxin-related protein 16 and its role in regulating transcription factor NF-κB activity.

Authors:  Pankaj Kumar Giri; Fan Jing-Song; Muthu K Shanmugam; Jeak Ling Ding; Gautam Sethi; Kunchithapadam Swaminathan; J Sivaraman
Journal:  J Biol Chem       Date:  2012-07-03       Impact factor: 5.157

4.  Regulation of the activity of the tumor suppressor PTEN by thioredoxin in Drosophila melanogaster.

Authors:  Zuohe Song; Negin Saghafi; Vijay Gokhale; Marc Brabant; Emmanuelle J Meuillet
Journal:  Exp Cell Res       Date:  2007-01-12       Impact factor: 3.905

5.  Molecular pharmacology and antitumor activity of palmarumycin-based inhibitors of thioredoxin reductase.

Authors:  Garth Powis; Peter Wipf; Stephen M Lynch; Anne Birmingham; D Lynn Kirkpatrick
Journal:  Mol Cancer Ther       Date:  2006-03       Impact factor: 6.261

6.  Immunohistochemical localization of adult T-cell leukaemia-derived factor, a human thioredoxin homologue, in human fetal tissues.

Authors:  S Fujii; Y Nanbu; I Konishi; T Mori; H Masutani; J Yodoi
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1991

7.  Thioredoxin and thioredoxin-interacting protein as prognostic markers for gastric cancer recurrence.

Authors:  Jae Yun Lim; Sun Och Yoon; Soon Won Hong; Jong Won Kim; Seung Ho Choi; Jae Yong Cho
Journal:  World J Gastroenterol       Date:  2012-10-21       Impact factor: 5.742

8.  Redox control of resistance to cis-diamminedichloroplatinum (II) (CDDP): protective effect of human thioredoxin against CDDP-induced cytotoxicity.

Authors:  T Sasada; S Iwata; N Sato; Y Kitaoka; K Hirota; K Nakamura; A Nishiyama; Y Taniguchi; A Takabayashi; J Yodoi
Journal:  J Clin Invest       Date:  1996-05-15       Impact factor: 14.808

9.  Overexpression of peroxiredoxin I and thioredoxin1 in human breast carcinoma.

Authors:  Mee-Kyung Cha; Kyung-Hoon Suh; Il-Han Kim
Journal:  J Exp Clin Cancer Res       Date:  2009-06-30

10.  Reduced levels of reactive oxygen species correlate with inhibition of apoptosis, rise in thioredoxin expression and increased bovine leukemia virus proviral loads.

Authors:  Amel Baya Bouzar; Mathieu Boxus; Arnaud Florins; Carole François; Michal Reichert; Luc Willems
Journal:  Retrovirology       Date:  2009-11-10       Impact factor: 4.602

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.